Flagship Ventures
VentureLabs
Venture Capital
Home
»
About
»
News/Media Resources
»
News Archive
VentureLabs
Venture Capital
About
Flagship Team
News/Media Resources
News Archive
Media Resources
Realized Investments
Events
Contact
LP Login
Search
News Archives
Company
Acceleron Pharma, Inc.
Accuri Cytometers, Inc.
Adnexus Therapeutics
Adolor Corporation
Adolor Corporation
Advanced Electron Beams, Inc
AeroDesigns Inc.
Affinity Express
Affinnova, Inc.
Agios Pharmaceuticals, Inc.
Alere Medical Incorporated
Alvine Pharmaceuticals, Inc.
Anesta Corporation
Antigenics
Antigenics
Aspect Medical Systems, Inc.
Astral Point
AudioLogic, Inc.
AudioLogic, Inc.
Avedro, Inc.
AVEO Pharmaceuticals, Inc.
BG Medicine, Inc.
BIND Therapeutics, Inc.
Bizo
Black Duck Software, Inc.
Blend Therapeutics Inc.
Blue Agave
Brainshark, Inc.
Brooks Fiber
BuyerZone
Carbon Design Systems
CardScan
Celera
Celera
Celexion LLC
Cerulean
CGI Pharmaceuticals, Inc.
Chantry Networks
ChemGenics Pharmaceuticals
ChemGenics Pharmaceuticals
Codon Devices
Color Kinetics
Color Kinetics
Concert Pharmaceuticals, Inc.
ContouR Pharmaceuticals
CYTYC
CYTYC
DataCore
Debt Exchange, Inc.
e-Dialog, Inc.
Eleven Biotherapeutics, Inc.
Ellacoya Networks
Ensemble Therapeutics Corporation
Epitome Biosystems
Everyday Solutions, Inc.
EXACT Sciences
Genomics Collaborative
Helicos BioSciences Corporation
Hypnion, Inc.
IDEXX Laboratories
INSMED, Incorporated
IntelliVid
Interactive Supercomputing Corporation
INTIO
Joule Unlimited, Inc.
LS9, Inc.
Mascoma Corporation
MedidaMETRICS, Inc.
Midori Renewables Inc.
moderna
Morphotek, Inc.
Novomer, Inc.
Oasys Water, Inc.
Ontogeny, Inc.
Permeon Biologics Inc.
PerSeptive BioSystems
Pervasis Therapeutics, Inc.
Pronutria
Quanterix Corporation
Receptos, Inc.
Renovis
Resolvyx Pharmaceuticals, Inc.
Seahorse Bioscience, Inc.
Selecta Biosciences, Inc.
Selventa
Seres Health
Seventh Sense Biosystems, Inc.
Somatogen
Syros Pharmaceuticals
Syros Pharmaceuticals
T2 Biosystems, Inc.
Tangent Medical Technologies Inc.
TARIS Biomedical, Inc.
Tetraphase Pharmaceuticals, Inc.
TransMedics, Inc.
TripAdvisor LLC
VisEn Medical, Inc.
Visterra, Inc.
WikiCell Designs
Zalicus
Ze-gen, Inc.
Zoom Info
Year
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
January 8, 2013
BIND Granted 5 US Patents for Medicinal Nanoengineering® Platform & Lead Drug Candidate, BIND-014
January 4, 2013
Receptos Doses First Patient in Phase 2 Trial for RPC1063 in Ulcerative Colitis
January 2, 2013
BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test
December 19, 2012
Moderna Therapeutics Announces Appointment Of Stephen Hoge, MD As Senior Vice President Of Corporate Development And New Drug Concepts
December 18, 2012
Blend Therapeutics Closes $16 Million in Series B Financing
December 18, 2012
Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer
December 11, 2012
BG Medicine Obtains CE Mark for CardioSCORE(TM) Test in Europe
December 10, 2012
Eleven Biotherapeutics Initiates Phase 1b Clinical Study of EBI-005, a Novel, Topically-delivered IL-1 Inhibitor Protein for the Treatment of Dry Eye Disease
December 10, 2012
T2 Biosystems Presents Data on Rapid and Direct Hemostasis Monitoring at ASH 2012
December 6, 2012
Moderna Announces $40 Million In Financing To Advance Development Of New Biotherapeutic Modality: Messenger RNA Therapeutics™
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »